YOU SEARCHED BY...
SEARCH BY...
Country
- Canada(9)
- Denmark(1)
- Estonia(1)
- France(1)
- Germany(1)
- Hong Kong(1)
- Hungary(1)
- India(2)
- South Korea(1)
- Spain(1)
- United Kingdom(1)
- United States(21)
Contract Service Directory
Stiris Research
Company Headquarters
2397 Oxford Street West
London, ON N6K 4P1
Canada
Contract Service Directory
Related Content
-
MHI Introduces Small-batch Blister Machine
Designed as a reliable, cost-effective solution for development stages, stability testing and initial small-batch production.02.02.23
-
Breaking News | Facilities | Industry News
Lilly to Invest $450M at Manufacturing Site in Research Triangle Park
Expansion includes additional parenteral filling, device assembly and packaging capacity to support an increased demand for Lilly's incretin products.01.30.23
-
Breaking News | Drug Development | Drug Discovery | Industry News
Rentschler Biopharma to Support Albert Einstein Discovery Center
Donates 50,000 Euros to support the creation of the discovery and activity center in Ulm.09.22.21
-
Breaking News | Industry News | Laboratory Testing
Metrion Biosciences Expands into New Cambridge HQ
New 12,000 sq. ft. Cambridge, UK premises more than doubles lab space.09.22.21
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials
Immunic Inc. Signs In-License Agreement with University Medical Center Goettingen, Germany
Covers the combination of DHODH inhibitors and nucleoside analogues to treat viral infections, including Covid-19.09.22.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
CuriRx Launches CuriLytics Platform for Biotherapeutic Development
To provide CMC analytical services to support complex biotherapeutic development using high resolution mass spectrometry.09.21.21
-
Biologics, Proteins, Vaccines | Reader Showcase
Thermo Fisher Launches Gibco AAV Production System
Aims to address the need to make adeno-associated virus (AAV) production more efficient and scalable.09.20.21
-
Breaking News | Promotions & Moves
Rentschler Biopharma Appoints Dr. Christian Schetter as Chief Scientific Officer
Schetter has a proven track record across the entire biopharmaceutical value chain.09.20.21
-
Breaking News | Collaborations & Alliances | Industry News
Asychem Partners with LaNova Medicines
Will provide one-stop services such as small molecule drugs, ADC project CMCs, R&D, production and IND China-US declaration.09.16.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Vaccine Developer Intravacc Adopts Hybrid Business Model
Aims to spur further innovation and sustainable growth over the next five years.09.16.21
-
Breaking News | Clinical Trials
Syneos Health Acquires Clinical Trial Recruitment and Retention Company StudyKIK
Accelerates product development by better connecting patients, sites and communities.09.15.21
-
Breaking News | Industry News
U.S. Govt. to Purchase Additional Doses of REGEN-COV Antibody Cocktail
Will supply an additional 1.4 million 1,200 mg doses of REGEN-COV to the U.S. government by January 31, 2022.09.15.21
-
Breaking News | Drug Development | Drug Discovery | Industry News | Information Technology
Novo Nordisk Launches Foundation Center for Genomic Mechanisms of Disease
Initiative, together with the Broad Institute of MIT and Harvard, aims to accelerate efforts to mine genetic data for insights into disease mechanisms.09.15.21
-
Breaking News | Industry News
U.S. Govt. Purchases Additional Doses of Lilly's Antibody Therapies for COVID
Will supply 388,000 doses of etesevimab to complement doses of bamlanivimab previously purchased, with approximately 200,000 doses expected to ship 3Q21.09.15.21
-
Breaking News | Industry News | Promotions & Moves
Aurion Biotech Makes Strategic Investments in Manufacturing
Appoints Tim Largen as VP of manufacturing to drive cell therapy production strategy and direct collaborations with leading CDMOs.09.14.21
-
Breaking News | Collaborations & Alliances | Industry News
Lakes BioScience Signs Agreement with Cytvia
Initiates the implementation of innovative workflows at Lakes BioScience’s factory in Cumbria.09.14.21
-
Drug Development | Laboratory Testing
Eliminating Endotoxins – Reagent Quality Testing for Cell and Gene Therapies
The importance of reagent quality control, especially endotoxin testing, during CGT development and the selection of reagents and suppliers to ensure safety.Garrett Perry, Technical Services Specialists at Teknova 09.14.21
-
Breaking News | CRO News | Drug Discovery | Industry News | Preclinical Outsourcing
Frontage Expands Early Drug Discovery Services
Acquires majority stake in Wuhan Heyan Biomedical Technology.09.14.21
-
Breaking News | Promotions & Moves
Eloxx Pharmaceutical Appoints Ali Hairiri as Chief Medical Officer
Hairiri will oversee clinical development efforts for the company’s pipeline of therapies to treat rare diseases.09.10.21
-
Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Boehringer Ingelheim, Twist Bioscience Enter Antibody Discovery Collaboration
Research collaboration covers multiple antibody research programs.09.10.21
-
Antimicrobial Resistance ‘Arms Race’ Realizes Advancements as Post-Antibiotic Era Ensues
Emerging innovations and non-antibiotic approaches to address urgent need to control infectious diseases, including multiple-drug resistant ‘super-bugs’.Merilee Kern, MBA, Brand Analyst, Strategist and Futurist, and Forbes Business Council Member 09.09.21
-
Clinical Trials
The Future of Clinical Trials
Dr. Greg Licholai of ICON plc on key market trends, the future of clinical trials and the acquisition of PRA.Kristin Brooks, Managing Editor 09.09.21
-
-
Let’s Get Genuine
LinkedIn sales pitches are going away in favor of being real.David G. Jensen, Contributing Editor 09.09.21
-
APIs | Clinical Trial Materials
Outsourcing the Manufacture of Clinical Trial APIs
What to consider when deciding to partner with a CDMO for manufacturing.Josh Hoerner, General Manager, Purisys 09.09.21
-
Drug Delivery
Inhaled Drug Delivery Trends
Designing dry powder devices for inhaled drugs.Andreas M. Meliniotis, Director of Device Development, Vectura 09.09.21
-
Clinical Trial Materials | Clinical Trials | Supply Chain
Clinical Trial Kitting
Overcome the challenges to make every sample count.Claudia Berrón and Arbi Harootoonian, Avantor 09.09.21
-
Analytical Services | Bioanalytical Services
Putting Laboratory Suppliers to the Test in the COVID Era – and Beyond
Build resiliency into analytical methods through careful consideration of chromatography partners.Hazel Dickson, PhD, Marketing Manager, Chemistry Group, Waters Corporation 09.09.21
-
Breaking News | Chemistry | Industry News | Laboratory Testing
Sterling Pharma Solutions Creates Flow Chemistry CoE
Completes initial phase of investment at its site in Dudley, UK for research into commercial applications of continuous flow chemistry.09.09.21
-
Breaking News | Drug Discovery | Industry News | Laboratory Testing
Frontage Shanghai Acquires Wuhan Heyan Biomedical
Provides target based in vitro pharmacodynamic screening and early pharmacological pharmacodynamic evaluation services.09.09.21
-
Breaking News | Industry News | Information Technology
Medrio and Phastar Partner to Leverage Metadata for Advanced Data Visualization
Aim to monitor compliance, patient burden and any anomalies that may ultimately impact the interpretation of results.09.08.21
-
cGMP Manufacture | Drug Development | QA/QC
Three Tips for Navigating Post-Approval Pharmacovigilance
Seamlessly transition from regulatory reporting to post-approval safety surveillance in today’s market.Emmanuel Belabe, Associate Vice President, Safety Product Management, ArisGlobal, Nina Patel Lahanis, Associate Vice President, Safety Science, EVERSANA 09.08.21
-
Breaking News | Clinical Trials | Collaborations & Alliances
LTO Network, Sphereon, Triall to Deliver COVID-19 Trials Anchored to Blockchain Tech
Will anchor research data to the blockchain, securing the integrity and security of clinical trial data.09.07.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
CEVEC, UCB Ink AAV Mfg. Technology Agreement
UCB will use of CEVEC’s ELEVECTA AAV manufacturing technology in gene therapy.09.07.21
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Adaptimmune, Genentech Enter Strategic R&D Collaboration
To research, develop, and commercialize cancer-targeted Allogeneic T-cell therapies.09.07.21
-
Clinical Trials | Information Technology
Clinical Trials are Transforming Right Before Our Eyes
Decentralized clinical trials, an innovation just a short time ago, are now mainstream.Kristin Brooks, Managing Editor, Contract Pharma 09.03.21
-
Promotions & Moves
Avacta Names Fiona McLaughlin as Therapeutics Division CSO
Dr. McLaughlin is a highly experienced oncology drug developer, bringing over 25 years of experience in research and translational drug development.09.02.21
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Secarna, Evotec Expand Strategic Antisense Discovery Pact
To discover, research and develop programs leveraging Secarna’s antisense oligonucleotide expertise with Evotec’s discovery and development capabilities.09.02.21
-
Bachem reports excellent results for the first half-year 2021
Sales of CHF 500 million are now expected for the year 2021.
-
Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | Laboratory Testing
FairJourney Biologics Expands into New Facilities
Newly purpose-built research center in Porto, Portugal supports rapid expansion.09.01.21
-
Breaking News | Drug Development | Industry News
Innovent Biologics, Bolt Biotherapeutics Enter Immuno-oncology Alliance
Will leverage Innovent's therapeutic antibody portfolio and discovery capability against undisclosed oncology targets in combination with Bolt's ISAC technology08.27.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
EOC Pharma and Chime Biologics Extend Partnership
For the CMC development of EOC202, a recombinant LAG-3 protein for cancer immunotherapy.08.26.21
-
Breaking News | Collaborations & Alliances
Cryoport and Mitsubishi Logistics Corporation Partner
Will work together to bring temperature-controlled supply chain solutions to Asia-Pacific.08.25.21
-
Breaking News | Collaborations & Alliances | R&D
Roche, Shape Therapeutics Enter Strategic Gene Therapy Collaboration
ShapeTX will apply its RNA editing platform and leverage its AAVid technology platform for the development of gene therapy for various diseases.08.25.21
-
Breaking News | Collaborations & Alliances
Lilly, Lycia Therapeutics Enter Multi-Year R&D Alliance
Will leverage Lycia's LYTAC protein degradation technology to discover, develop and commercialize targeted therapeutics in immunology and pain.08.25.21
-
Bachem and Novo Nordisk Redesign SPPS for Green Chemistry
Replacing gold standard solvents to provide a greener alternative.
-
APIs
Propofol – A Bachem Success Story
The COVID-19 pandemic has rapidly expanded awareness of the API Propofol, produced by Bachem in Vionnaz.
-
Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
McMaster, Sartorius Enter Biomanufacturing Partnership
Team up to advance biomanufacturing processes with next-gen tech.08.23.21
-
Bio News | Breaking News | Industry News
Pfizer to Acquire Trillium Therapeutics for $2.3B
Strengthens oncology portfolio with addition of next-generation, investigational immuno-therapeutics for hematological malignancies.08.23.21
-
Breaking News | Industry News | Promotions & Moves
J&J CEO Alex Gorsky to Step Aside
Company will transition the CEO role to Joaquin Duato at the start of 2022.08.23.21
-
Bioanalytical Services
Ensuring Equitable Access to Next-generation Sequencing in Oncology
Recent advances in sequencing techniques have transformed cancer treatment.Gang Song, Ph.D., CEO & Co-Founder, Pillar Biosciences 08.20.21
-
Bio News | Breaking News | Industry News
PBS Biotech Scales-Up Manufacturing Solutions for Cell Therapies
Raises $10 million to grow its product offerings and capabilities.08.20.21
-
Breaking News | Facilities | Industry News
Sai Life Sciences Opens New Biology Facility in Hyperbad, India
Positions itself as a differentiated player in Discovery Biology.08.19.21
-
Breaking News | CRO News | Industry News
BioAgilytix Acquires MicroConstants
The business will complement BioAgilytix's contract research services for the pharmaceutical and biotech industry.08.19.21
-
APIs | Breaking News | Facilities | Industry News
Curia to Expand U.S. Commercial Manufacturing Capability
Roughly $35 million will be invested to expand manufacturing and product-handling solutions for complex small molecules.08.19.21
-
Drug Development | Drug Discovery
Antimicrobial Resistance ‘Arms Race’ Realizes Advancements as Post-Antibiotic Era Ensues
Emerging innovations and non-antibiotic approaches to address urgent need to control infectious diseases, including multiple-drug resistant ‘super-bugs’Merilee Kern 08.18.21
-
Breaking News | Drug Development | Drug Discovery | Industry News | Laboratory Testing
Astellas, LabCentral Partner to Help Emerging Biotechs Accelerate Research
Future Innovator Prize offers one-year use of LabCentral's state-of-the-art lab facility in Cambridge, MA and access to Astellas' R&D capabilities.08.18.21
-
Breaking News | Industry News | Promotions & Moves
-
Clinical Trials | Information Technology
Enabling Decentralized Clinical Trials through Digital Transformation
Adopting a strategy of “bringing the technology to the data.”Temitope Keyes, Executive Director, Business Development at Cmed Technology 08.17.21
-
Breaking News | Collaborations & Alliances | Drug Development
Cytocom to Fund Research and Lab Facilities at the La Jolla Institute for Immunology
The research will support the development of potential treatments of cancer, infectious, autoimmune & chronic inflammatory diseases.08.13.21
-
Clinical Trials | Cold Chain Management | Logistics
Flexible Ultracold Chain Critical to Decentralized Clinical Trials
Addressing barriers to further grow and accelerate the adoption of patient-focused DCTs.Timothy Root, Marketing Director, Stirling Ultracold 08.12.21
-
Biologics, Proteins, Vaccines | Breaking News | Promotions & Moves
Discovery Life Sciences Appoints Cell & Gene Therapy CTO
Dr. Clarke will work to further establish the company as a global leader in cell and gene therapy materials and analytical services.08.12.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
Lonza, Sheba Medical Center Leverage Cocoon Platform for Cell Therapy
Customizable, patient-scale cell therapy platform aims to streamline manufacturing to improve process efficiency and reliability.08.12.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Aldevron, Ginkgo Bioworks Partner on mRNA Vax Mfg. Breakthrough
Achieved improvements in manufacturing yield of vaccinia capping enzyme (VCE), a component often required to produce mRNA therapies and vaccines.08.11.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Lumen Bioscience, Google Partner to Apply ML to Biologics Manufacturing
Aims to double biomanufacturing productivity.08.11.21
-
Breaking News | R&D
Amgen, USC Provide Researchers Access to Thermo Scientific Cryo-EMs
Access to Krios and Glacios microscopes allows researchers from both institutions to combine resources to bring more speed and power to their research.08.10.21
-
cGMP Manufacture | Drug Development | Promotions & Moves
Syngene Adds Senior Leadership in the U.S.
Alex Del Priore appointed Senior Vice President, Manufacturing Services, and Alan Collis appointed Vice President, Integrated Drug Discovery Services.08.06.21
-
Clinical Trials | Information Technology
Leveraging Clinical Trial Outcomes Through Medication Adherence
Addressing adherence and trial failure, the problem with traditional methods, and the smart way to monitor adherence.Bernard Vrijens, CEO & Scientific Lead, AARDEX Group 08.05.21
-
Breaking News | Industry News | Packaging & Tracking
SiO2 Receives $64M Contract from US Government
Supports additional infrastructure of the company's primary packaging containment system platform for storing vaccines and therapeutics.08.05.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Amgen Investing $550M in New Biomanufacturing Facility
Will create 355 new jobs at Holly Springs, NC site.08.05.21
-
Breaking News | Financial Reports
Amgen's 2Q Results
Product sales up 3% in the quarter while earnings were impacted by $1.5 billion in acquired in-process R&D.08.04.21
-
Breaking News | Financial Reports
BMS 2Q Revenues up 16%
Top sellers Revlimid, Eliquis and Opdivo drive growth while established brands were down 64%.07.30.21
-
Breaking News | Facilities | Industry News
Regeneron Investing $1.8B in Tarrytown, NY Campus
New York's largest biotech company creating an additional 1,000 jobs over five years.07.29.21
-
Breaking News | Facilities | Industry News
Nexus Pharmaceuticals Opens State-of-the-Art Manufacturing Facility
Phase I investment of $100 million supports a new three-story manufacturing facility.07.29.21
-
Breaking News | Facilities | Industry News
Celanese Opens Pharma Drug Delivery Feasibility Lab
State-of-the-art R&D lab at Florence, KY site expands technical feasibility capabilities for long-acting delivery of small molecules, biologics and nucleotides.07.29.21
-
Breaking News | Industry News | Promotions & Moves
Sterling Pharma Solutions Appoints Ian Baxendale to Lead Dudley, UK Site
Baxendale has over 20 years of academic and industrial experience within organic synthesis.07.29.21
-
Breaking News | Industry News
Amgen to Acquire Teneobio for $900M
Includes Teneobio's bispecific and multispecific antibody technologies, heavy-chain only platform and T-cell engager platform.07.28.21
-
Breaking News | Clinical Trials | Drug Development | Industry News | Information Technology
Almac, THREAD to Integrate Technologies for Clinical Trials
Integrating technology platforms aims to provide sponsors and CROs with a full range of tools designed to reduce the risk of trial delays.07.28.21
-
Promotions & Moves
ImmunoGenesis Opens Research Lab, Adds Key Roles
To support the expansion of the company's recently licensed key development assets, clinical and business development activities.07.28.21
-
Breaking News | Industry News | Laboratory Testing
Cerba Research Wins NIH Contract for Central Lab Services
To provide clinical lab screening and safety testing for NIAID-supported clinical trials in the area of infectious disease.07.28.21
-
Laboratory Testing | Reader Showcase
Pall Launches Minimate EVO Filtration System
Designed to allow high productivity, reproducibility, and simple control compared to stirred-cell technologies.07.27.21
-
Biologics, Proteins, Vaccines | Drug Development
AAV-Mediated Gene Therapy: Quantifying Viral Titer and Integrity
Droplet Digital PCR offers precise potency data, critical for the proper dosing of gene therapies.Mark White and Marwan Alsarraj , Digital Biology Group at Bio-Rad 07.27.21
-
Breaking News | R&D
Metrion Biosciences Appoints Nick Foster as Chief Commercial Officer
The appointment forms part of the company’s growth strategy for 2021 and 2022, with a focus on the USA, EU and Japan.07.26.21
-
Breaking News | CRO News | Industry News
Calyx Expands US Presence in Response to Growing Demand
RTP-based US headquarters established to meet pharmaceutical companies’ and CROs’ increasing needs for e-clinical and regulatory solutions.07.22.21
-
Bioanalytical Services | Biologics, Proteins, Vaccines | Filtration & Purification | QA/QC | Reader Showcase
MOBILion Launches MOBIE HRIM for Biotherapeutic Drug Development
Designed to address characterization challenges during biopharmaceutical drug development and quality monitoring.07.21.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Intravacc's Inactivated Polio Vaccine Out-licensed to Sinovac
Sinovac's Eupolio vaccine (sIPV) receives market authorization from the NMPA in China.07.20.21
-
Clinical Trials | CRO News | Information Technology | Reader Showcase
Quanticate Launches Updated Remote Source Data Verification Platform
Cloud-based application allows verification of multiple clinical research sites’ source data to be completed remotely by specialist team at centralized location07.19.21
-
Breaking News | Clinical Trials | Industry News | Information Technology
Calyx Opens U.S. HQ Near Research Triangle Park
RTP-based headquarters established to meet growing needs for eClinical and regulatory services.07.19.21
-
-
-
Breaking News | CRO News | Facilities | Industry News
CRO Charnwood Molecular Expands Capabilities
$75m construction project in Loughborough creates flexible facility for the growing CRO.07.16.21
-
Clinical Trials | Information Technology | Reader Showcase
Almac Offers Expedited IRT Solutions for COVID-19 Trials
Launches the expedited deployment and support of multiple Interactive Response Technology (IRT) solutions in support of COVID-19 treatments07.16.21
-
Analytical Services | Supply Chain
Drug Product Safety and Security
Is it even possible in an elongated supply chain?Emil Ciurczak, President, Doramaxx Consulting 07.16.21
-
Breaking News | Clinical Trials | Industry News | Information Technology
Medable Opens EMEA HQ in Dublin
Expands European presence to grow market for decentralized clinical trials.07.15.21
-
APIs | Breaking News | cGMP Manufacture | Industry News
MediPharm Labs Receives Canadian GMP Pharmaceutical DEL
License can be used for manufacturing, testing and sale of APIs and pharmaceutical drug products containing cannabis.07.15.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News | Parenterals
Batavia Manufactures IAVI’s Lassa Fever Vax Candidate
Uses innovative 'scale-X' bioreactor to support Phase I clinical trials.07.14.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Curia to Acquire US-based LakePharma
Expanding end-to-end R&D capabilities and scale for biologics.07.14.21
-
-
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Fill/Finish | Formulation Development | Industry News | Lyophilization
-
Breaking News | Industry News
AMRI Becomes Curia
New brand reinforces ongoing expansion of expertise, capabilities and contributions to health care.07.12.21
-
Breaking News | Industry News
Sequanta, Mission Bio Enter Strategic Pact
Provides high-quality single-cell sequence services using Mission Bio's products to customers in mainland China.07.09.21
-
Nanotechnology & Medtech: A New Frontier
Three reasons why U.S. medtech companies go overseas for nanotechnology research.Rachel Shelly, Head of Medical Technologies, IDA Ireland 07.09.21
-
APIs | Breaking News | GMPs/GCPs | Industry News | QA/QC
Purisys Obtains Two Global ISO Certifications
Now certified for ISO 17025 for Testing and Calibration Laboratories and ISO 17034 for Reference Material Producers.07.08.21
-
Biologics, Proteins, Vaccines | cGMP Manufacture
Can mRNA Facilities Really be Flexible?
Four key questions to accommodate growth and expansion.Jeff Heil, PE , Novel Therapy SME, DPS Group Global 07.08.21
-
Breaking News | Promotions & Moves
Thermo Fisher Names New Chief Medical Officer
Alan Sachs will assume the newly established role.07.07.21
-
Breaking News | Drug Development | Drug Discovery | Industry News | Information Technology
SRI, Sanofi Enter Drug Discovery Collaboration
Will leverage SynFini, SRI’s artificial intelligence and automation platform to accelerate development of small-molecule drug targets.07.07.21
-
Collaborations & Alliances | Drug Development
Y-Biologics, Pierre Fabre Enter Immuno-oncology Alliance
Aims to develop and commercialize a family of human antibodies to inhibit the growth of tumor cells.07.07.21
-
Mimetas, Roche to Develop Human Disease Models for Drug Development
Will focus on tailor-made phenotypic models for IBD and HBV.07.06.21
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
BioMed X Expands Collaboration with Merck
Launches a new joint research program in oncology.07.06.21
-
Breaking News | Promotions & Moves
Avid Bioservices Appoints Esther M. Alegria to Board
Former SVP of global manufacturing at Biogen bring nearly 30 years of biopharmaceutical industry experience.07.02.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Aragen Expands Discovery Research Agreement with Boehringer Ingelheim
Aims to accelerate the discovery pipeline of Boehringer Ingelheim.07.01.21
-
Breaking News | Collaborations & Alliances | Industry News
Innovent Biologics Signs License Agreement with Synaffix
Synaffix will provide proprietary ADC technologies to enable Innovent to rapidly progress one of its antibodies as a best-in-class ADC candidate.07.01.21
-
APIs | Breaking News | Facilities | Industry News
Almac Expands Crystallization Capabilities
A new Empyrean X-ray powder diffractometer is part of the investment.07.01.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Sanofi Launches Dedicated mRNA Vaccines CoE
Approximately €400million investment annually aims to accelerate end-to-end R&D of next-generation vaccines.06.30.21
-
eTheRNA, Quantoom Collaborate to Develop Novel RNA Production System
Aims to develop an RNA production system for both research and GMP-grade material.06.29.21
-
Breaking News | Clinical Trials | Collaborations & Alliances | Industry News | Information Technology
CMIC and Lokavant Partner to Deploy Clinical Trial Intelligence Platform
Enter first phase of multi-year partnership to deploy predictive analytics platform for monitoring and management of clinical trials in Asia-Pacific.06.29.21
-
Formulation Development
Tryp Therapeutics Partners with Alcami for Proprietary Formulations
The agreement represents another step toward the proprietary manufacturing, formulation, and delivery of products for Tryp’s PFNTM program.
-
Clinical Trials | Information Technology
The Power and Promise of Decentralized Trials
Clinical researchers turned to a range of digital solutions to address the effects of the COVID-19 pandemic on trials.Derk Arts, CEO, Castor 06.25.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Genezen Breaks Ground on cGMP Lentiviral Vector Production Facility
First phase will see the construction of a 25,000 square feet site including a process development lab expansion.06.25.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Process Development
Catalent to Acquire RheinCell Therapeutics
Strengthens path towards industrialization of induced pluripotent stem cell-based therapies.06.25.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Discovery | Facilities | Industry News
AbCellera to Build Antibody Manufacturing Facility in Canada
130,000-square-foot Vancouver facility aims to accelerate the development of antibody-based therapies for an array of medical conditions.06.23.21
-
Breaking News | Industry News | Preclinical Outsourcing
Vectura, Incannex Enter Preclinical Services Agreement
Vectura to provide development services for IHL-216A, Incannex’s inhaled drug product for the treatment of traumatic brain injury.06.22.21
-
Breaking News | Collaborations & Alliances
Iksuda, LegoChem Expand ADC Alliance
Grants Iksuda access to LegoChem's next generation ADC platform for up to six targets.06.22.21
-
Breaking News | Clinical Trials | CRO News
Syneos Expands Decentralized Trial Capabilities
Aims to accelerate decentralized clinical trial delivery through collaboration with site sponsors.06.22.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Danaher To Acquire Aldevron for $9.6B
Aldevron will operate as a standalone operating company and brand within Danaher's Life Sciences segment.06.21.21
-
Breaking News | Facilities | Formulation Development | Industry News
Coriolis Pharma Expands ATMP Development Facilities
Construction of new facilities for ATMP formulation development up to biosafety level S2 are in progress and operations are expected to start by 4Q21.06.21.21
-
Breaking News | Collaborations & Alliances | Drug Development
Jacobio Earns $20M AbbVie Milestone
Initiates Phase 1/2a trial of SHP2 inhibitor JAB-3312 in combination with PD-1 antibody Pembrolizumab and MEK inhibitor Binimetinib.06.18.21
-
Breaking News | Industry News | Laboratory Testing
-
Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Sanofi Invests $425M in Flu Vaccine Manufacturing Facility
Newly licensed U.S. manufacturing facility to increase availability of Fluzone High-Dose Quadrivalent.06.17.21
-
Breaking News | Facilities
Thermo Scientific Upgrades Ultra-Low Temperature Freezers
The TSX Series ULT Freezers reliably preserve stored materials in an environmentally and user-friendly design.06.16.21
-
Breaking News | Collaborations & Alliances | Drug Development | Formulation Development
Lumen Bioscience, Novo Nordisk Enter Metabolic Research Pact
To explore Lumen's drug development and manufacturing platform to deliver oral biologics for cardiometabolic disease.06.16.21
-
Tablet Development Process Training - July 20-21
This course provides comprehensive insight into the tablet development process to provide powerful tools that you can put to work immediately.
-
Breaking News | Industry News
GENinCode, EVERSANA Enter Major U.S. Commercialization Pact
EVERSANA will support launch and commercialization in the U.S. market for GENinCode’s portfolio of polygenic cardiovascular disease products.06.14.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
ProCell for Patient Project to Develop Automated Production Unit for CAR-T Cell Therapies
Standardized and automated manufacturing aims to reduce the amount of work on producing CAR-T cells by 50 percent.06.10.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Process Development
Portonbio Enters CAR-T Partnership with KAEDI
CDMO will provide KAEDI with CMC services for multiple projects.Tim Wright, Editor, Contract Pharma 06.07.21
-
Bio News | Breaking News | cGMP Manufacture | Facilities | Industry News
Fusion to Build Radiopharma Manufacturing Facility
New 27,000 square foot site will be operational by 2024.Tim Wright, Editor, Contract Pharma 06.07.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
VIVEbiotech Launches Lentiviral Vectors Mfg. Plant
Increases production capacity by 400% to deliver commercial-size batches for Cell and Gene Therapy Sector.Kristin Brooks 06.04.21
-
Clinical Trials | CRO News | Drug Development | Information Technology
Driving Efficiencies in Today’s Complex Trials
Murray Aitken of IQVIA discusses CRO market trends, post-pandemic opportunities, and leveraging tech-enabled services and capabilities.Kristin Brooks, Managing Editor, Contract Pharma 06.03.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Samsung Biologics Signs Agreement with Kahr Medical
Will support Kahr’s drug candidate DSP502, a TIGITxPD1 fusion protein.Charles Sternberg, Assistant Editor 06.03.21
-
Clinical Trials | Drug Development
The Future is Decentralized: What This Means for Clinical Trial Sites
Benefits for research sites and how to prepare for decentralized trials.Marc Leighton, Vice President of Product at Florence Healthcare 06.02.21
-
Bioanalytical Services | Bioassay Development | Biologics, Proteins, Vaccines
The Future of Continuous Bioprocessing
The modernization of advanced therapy manufacturing.Dr. Karoline Hahn, Senior Consultant for Advanced Therapies, KCR 06.02.21
-
Breaking News | Collaborations & Alliances
Aptamer Group Collaborates with PinotBio
Will work together to develop new therapeutic drug conjugates.Charles Sternberg, Assistant Editor 06.02.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
CCRM Enters Regenerative Medicine Partnerships
Signs agreements with Canadian and international institutions to advance regenerative medicine inventions.Tim Wright, Editor, Contract Pharma 06.01.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Thibault Jonckheere Named CEO of Exothera
The viral vector CDMO spinoff of Univercells is making an intranasal vaccine candidate for Covid-19 treatment.Tim Wright, Editor, Contract Pharma 06.01.21
-
Bioanalytical Services | Biologics, Proteins, Vaccines
The Future of Continuous Bioprocessing
The Modernization of Advanced Therapy ManufacturingDr. Karoline Hahn, Senior Consultant for Advanced Therapies, KCR 05.27.21
-
Breaking News | Collaborations & Alliances | Industry News
Hovione and iBET Form Strategic Collaboration
Will combine knowledge from both partners to create innovation in new therapeutic fields.Tim Wright, Editor, Contract Pharma 05.27.21
-
Bio News | Breaking News | Industry News
August Bioservices Expands U.S. Biopharma Manufacturing Capabilities
$23.6 million investment from Polaris Partners will expand manufacturing capacity and capabilities to support production of sterile injectables.Tim Wright, Editor, Contract Pharma 05.27.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
The Discovery Labs Signs Lease with UPenn's Gene Therapy Program
The University will use Discovery Labs’ campus for a portion of its research operations focused on the development of genetic medicines.Charles Sternberg, Assistant Editor 05.27.21
-
Biologics, Proteins, Vaccines | Breaking News
Dyadic Collaborates with Syngene to Develop Covid-19 Vaccine Candidate
Will develop a candidate to immunize people against current and future variants.Charles Sternberg, Assistant Editor 05.26.21
-
Biologics, Proteins, Vaccines | Clinical Trials | Drug Development
Gene Therapy Trials
Critical regulatory and study start-up questions for gene therapy trials in the U.S., UK, and Europe.April Marquick, Cell and Gene Therapy Expert, Premier Research 05.26.21
-
Clinical Trials | Drug Development | Information Technology
Clinical Development Trends
Digital modernization, decentralized trials, and advanced therapies drive outsourcing of clinical trials.Kristin Brooks, Managing Editor, Contract Pharma 05.25.21
-
Breaking News | Promotions & Moves
Sterling Pharma Appoints Stewart Mitchell as New Site Head
Will lead new antibody-drug conjugate (ADC) facility in Deeside, UK.Kristin Brooks 05.24.21
-
Breaking News | CRO News | Industry News
Premier Research Acquires Camargo Pharmaceutical Services
Expands product planning, development and differentiation services offered.Tim Wright, Editor, Contract Pharma 05.21.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development
Thermo Fisher, UCSF to Open Cell Therapy cGMP Mfg. Center
Thermo Fisher will build and operate a 44,000-sq.-ft. cell therapy development, manufacturing and collaboration center on UCSF's Mission Bay campus.Kristin Brooks 05.20.21
-
Breaking News | Industry News
ACG Wins iF Award for ‘Karton X’
Karton X is a high-speed cartoner with an output of 300 items per minute.Charles Sternberg, Assistant Editor 05.19.21
-
Breaking News | Collaborations & Alliances | Industry News
Univercells Technologies Collaborates with NIBRT
Adds scale-X carbo integrated system at Dublin facility for intensified upstream viral manufacturing demonstrations and training.Charles Sternberg, Assistant Editor 05.19.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News
Gamma Biosciences Acquires Stake in Mirus Bio
Supports Mirus’ expansion of GMP production of its flagship product TransIT VirusGEN for large scale manufacturing of AAV and LV viral vectors for gene therapy.Kristin Brooks 05.18.21
-
Breaking News | Promotions & Moves
BioNTech SE Appoints Jens Holstein as CFO
Holstein succeeds Dr. Sierk Poetting.Charles Sternberg, Assistant Editor 05.18.21
-
Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News | R&D
R&D Alliance for Eye Disease Cell Therapies
BlueRock Therapeutics, Fujifilm Cellular Dynamics, and Opsis Therapeutics enter R&D pact to discover and develop cell therapies for eye diseases.Tim Wright, Editor, Contract Pharma 05.17.21
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News | R&D
BioMedX Extends Collaboration with Merck
Merck will support up to six more research groups at the BioMed X Institute in Heidelberg within the next six years.Charles Sternberg, Assistant Editor 05.17.21
-
Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Industry News
PerkinElmer Acquires Nexcelom Bioscience
Bolsters preclinical portfolio and enhances QA/QC capabilities in cell and gene therapy and biologics manufacturing.Tim Wright, Editor, Contract Pharma 05.17.21
-
Breaking News | Industry News | Promotions & Moves
Matica Biotech Names Dr. Yun Jeong Song as CEO
Song's background spans more than 20 years of basic research, patient care and biopharmaceutical industry leadership.Charles Sternberg, Assistant Editor 05.13.21
-
Breaking News | Promotions & Moves
New Amsterdam Sciences Appoints Executive Vice President
Dr. Christopher van de Wetering brings decades of governmental experience.Charles Sternberg, Assistant Editor 05.12.21
-
Breaking News | Industry News
HBC, Catalent Enter Innovative Softgel Alliance
Partnership will leverage Catalent’s OptiGel DR technology to develop a delayed-release formulation of HBC’s OmeGo fish oil.Kristin Brooks 05.12.21
-
Breaking News | Clinical Trials | CRO News
Emmes Acquires Orphan Reach
Establishes Emmes as an industry leader in clinical research for orphan and rare diseases.Kristin Brooks 05.12.21
-
Bio News | Breaking News | Facilities
NJ Bio Moves Headquarters to Princeton, New Jersey
The 35,000-square-foot site was formerly occupied by Bristol Myers Squibb.Tim Wright, Editor, Contract Pharma 05.11.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
IDRI, Duke Vax Institute, 3M Partner on Adjuvant COVID Vax
Studies show 3M-052/Alum formulation elicits a strong, durable immune response against several strains of coronavirus, including bat coronaviruses.Kristin Brooks 05.10.21
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
3P and Buzzard Pharmaceuticals Enter Cancer Collaboration
Enter into a partnership agreement for manufacturing of the potent IL-1 inhibitor Isunakinra.Charles Sternberg, Assistant Editor 05.07.21
-
APIs | Breaking News | Collaborations & Alliances | Cytotoxics and High Potency Manufacturing | Industry News
FDA Approves ADC Therapeutics' Zynlonta
ADC collaborated with CDMO Sterling Pharma Solutions to develop the cancer drug.Tim Wright, Editor, Contract Pharma 05.07.21
-
Breaking News | Collaborations & Alliances | Industry News | Packaging & Tracking | Serialization
Yangtze River Pharmaceutical Group Selects TraceLink Solution to Aid Growth
Will use TraceLink’s applications and digital supply network to comply with track and trace requirements in multiple markets.Charles Sternberg, Assistant Editor 05.07.21
-
Breaking News | Drug Development | R&D
Crown Bioscience Acquires OcellO
Expands its portfolio of in vitro services.Charles Sternberg, Assistant Editor 05.06.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances
ADC Therapeutics Receives FDA Approval for Zynlonta
ADC collaborated with Sterling Pharma Solutions to develop Zynlonta.Charles Sternberg, Assistant Editor 05.06.21
-
Breaking News | Drug Delivery | Drug Development | Industry News
Vectura, Inspira Partner to Develop Inhaled COVID Treatment
Further testing and development work to prepare for Phase 1 studies using its FOX vibrating mesh nebulizer to deliver IPX formulations.Kristin Brooks, Contract Pharma 05.06.21
-
Are Your Suppliers Supporting Your Growth?
The role of strategic sourcing and procurement for emerging biopharmaceutical companies.Dave Stowe and Jonathan Horn, Tunnell Consulting 05.05.21
-
Breaking News | cGMP Manufacture | Industry News | Information Technology
Autolomous to Expedite Digitization of Batch Verification
Will work to develop AutoloMATE-Assist, a digital batch verification technology for cell and gene therapies to alleviate paper based bottlenecks.Kristin Brooks 05.04.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News | R&D
Albumedix Extends Research Collaboration with Cobra Biologics
Collaboration investigates enhanced manufacturing of AAV and lentiviral vectors to improve quality and productivity for gene therapy and vaccine developers.Tim Wright, Editor, Contract Pharma 05.03.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
CCRM and Amgen Partner to Advance Emerging Medical Innovations
New fund to support regenerative medicine discoveries with high potential impact for patients.Tim Wright, Editor, Contract Pharma 05.03.21
-
Analytical Services | Bioanalytical Services | Breaking News | cGMP Manufacture | Drug Development | Industry News | R&D
AMRI Adds R&D and Mfg. Solutions for Orphan Products
Targeted investments globally expand scale and compound handling capabilities at facilities in Albany, Grafton, and Glasgow.Kristin Brooks 04.30.21
-
Formulation Development
Melt Extrusion and How Helps Advance New Medicines
Bernd Liepold, Ph.D. of AbbVie explains melt extrusion and how it works in the formulation of new medicines.
-
Breaking News | Industry News | Promotions & Moves
Frontage Laboratories Appoints Executive Director, Regional Head of Sales, West
John Foster will be accountable for overseeing business development efforts in the western US.Charles Sternberg, Assistant Editor 04.29.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
GenScript Launches Research Lentiviral Vector Packaging Service
Enables scientists to package their genetic material of choice to ensure consistent production of functional and intact viruses.Charles Sternberg, Assistant Editor 04.29.21
-
Analytical Services | Bioanalytical Services | Breaking News | CRO News | Facilities | Industry News
PPD to Expand GMP Lab in Ireland
Adding cell and gene therapy capabilities to support growing customer need.Tim Wright, Editor, Contract Pharma 04.29.21
-
Breaking News | Cold Chain Management | Collaborations & Alliances | Industry News | Packaging & Tracking
Catalent and Stirling Ultracold Enter Cold Chain Partnership
To establish energy-efficient cold chain capabilities for biologics and emerging modalities.Tim Wright, Editor, Contract Pharma 04.29.21
-
Biologics, Proteins, Vaccines | Breaking News
Introducing ViroCell Biologics
The UK’s first clinical trial focused viral vector manufacturer.Charles Sternberg, Assistant Editor 04.28.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Valneva Focuses on Bilateral Discussions to Supply COVID-19 Vax
Looks to secure a supply agreement for the only inactivated vaccine candidate in clinical trials against COVID-19 in EU.Kristin Brooks 04.22.21
-
Clinical Trials | CRO News | Information Technology
Syneos, Medable Partner for New Decentralized Capabilities
Aims to increase clinical trial diversity and improve patient access and experiences with fit-for-purpose decentralized digital solution.Kristin Brooks 04.22.21
-
Breaking News | Collaborations & Alliances | Industry News
Kintor, Visum Enter COVID-19 Manufacturing Partnership
To expand proxalutamide manufacturing for treatment of COVID-19 patients.Tim Wright, Editor, Contract Pharma 04.19.21
-
Breaking News | Drug Development | Industry News
Evotec Enters Master Service Agreement with Kazia Therapeutics
Will work together to make EVT801 available to patients globally.Charles Sternberg, Assistant Editor 04.19.21
-
Breaking News | Drug Development | Industry News
Bristol Myers Squibb Expands at Cambridge Crossing
Adds remaining 113,000 square feet to its initial lease at 250 Water Street.Kristin Brooks 04.16.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Abenza Chooses North Carolina for New Biologics Manufacturing Site
GMP manufacturing will commence in mid-2022.Charles Sternberg, Assistant Editor 04.15.21
-
Breaking News | CRO News | Industry News
Thermo Fisher Acquires PPD for $17.4B
Further expands service offering to pharma and biotech customers.Tim Wright, Editor, Contract Pharma 04.15.21
-
Breaking News | Industry News | Information Technology
Arkema Recruits Dotmatics as its R&D Digitalization Partner
Agreement supports Arkema’s project to modernize access to R&D data and reduce design times for new products.Charles Sternberg, Assistant Editor 04.15.21
-
Breaking News | Drug Development | Industry News
BioVersys Gets EIB Funds to Address Antimicrobial Resistance
Financing supports development of BioVersys’ breakthrough hospital antibiotic therapy targeting Acinetobacter baumanniiKristin Brooks 04.14.21
-
Breaking News | Industry News | Microbiology
Microbiologics Expands Virology Services
Increases capabilities and capacity to provide anti-infective testing, assay development and biomaterial production services for highly infectious pathogens.Kristin Brooks 04.14.21
-
Breaking News | Promotions & Moves
Executive Moves: Novavax
Gale Smith named SVP, Discovery and Pre-Clinical Research and Chief Scientist, and Troy Morgan named SVP, Chief Compliance Officer.Kristin Brooks 04.14.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Sanofi Acquires Tidal Therapeutics
Gains novel mRNA-based technology with research capabilities in immuno-oncology and inflammatory diseases, with potential in other disease areas.Kristin Brooks 04.12.21
-
Breaking News | Clinical Trials | CRO News | Industry News
Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
Offers full-service human absorption, metabolism, and excretion (hAME) studies with radiolabeled compounds.Tim Wright, Editor, Contract Pharma 04.09.21
-
Analytical Services | Bioanalytical Services | Breaking News | Industry News
Agilex Biolabs Acquires TetraQ for APAC Expansion Plans
Specializes in bioanalysis of small molecules and biologics for PK, immunogenicity, biomarker and immunological pharmacodynamics assessments.Kristin Brooks 04.08.21
-
Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | Information Technology
Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals
Supporting R&D optimization of next-generation biopharmaceuticals with digital technology and drug discovery platform.Tim Wright, Editor, Contract Pharma 04.07.21
-
Breaking News | Clinical Trials | CRO News | Drug Development
Moleculin Selects IQVIA Biotech to Advance COVID Treatment
IQVIA to manage the company's effort to begin potential clinical trials of WP1122 for the treatment of COVID-19.Kristin Brooks 04.06.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | Parenterals
Sanofi to Build New $700M Flu Vaccine Facility in Canada
Facility will be located in Toronto and will increase supply of influenza vaccines in Canada, the U.S. and Europe.Tim Wright, Editor, Contract Pharma 04.05.21
-
Breaking News | Industry News | Information Technology
LabVantage Solutions Expands and Improves its Portfolio
Unveils two new solutions and an updated version of its flagship LIMS platform.Charles Sternberg, Assistant Editor 04.05.21
-
Breaking News | Excipients | Facilities | Industry News
Crystec Launches New R&D Center in China
New site in Haimen, Jiangsu province has been established following an invitation to participate in the Yangtze Delta Advanced Drug Development platform.Tim Wright, Editor, Contract Pharma 04.05.21
-
Bioanalytical Services | Breaking News | CRO News | Industry News
Charles River Acquires Retrogenix
Strengthens scientific expertise with the addition of cell microarray technology and off-target profiling for drug discovery.Tim Wright, Editor, Contract Pharma 04.05.21
-
Clinical Trials | Drug Development | QA/QC
RBQM Comes of Age: COVID as a Catalyst for Change
Clinical trial conduct has undergone a fundamental shift over the last year – and things will never be the same again.Kristin Brooks, Managing Editor 04.01.21
-
Breaking News | Drug Development
Servier Acquires Agios Pharmaceuticals’ Oncology Portfolio
Expands its oncology leadership capabilities in the U.S.Charles Sternberg, Assistant Editor 04.01.21
-
Analytical Services | APIs | cGMP Manufacture | Excipients | Formulation Development | QA/QC | R&D | Solid Dosage/Semi-solids
Enteris BioPharma: Custom Solutions – From Bench to Market
CDMO operations are housed within a 32,000-square-foot, FDA-inspected and cGMP-compliant facility in northern New Jersey.
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Ajinomoto, Bright Peak Enter Immunocytokines Research Pact
Exclusive license agreement to incorporate Ajinomoto Co.’s AJICAP site-specific bioconjugation technology for the development of Bright Peak Immunocytokines.Kristin Brooks 03.30.21
-
Breaking News | cGMP Manufacture | Collaborations & Alliances
BioCentriq, Kytopen Enter Cell Therapy Alliance
Demonstrates the impact of transformative technology on cell therapy manufacturing.Charles Sternberg, Assistant Editor 03.24.21
-
Breaking News | R&D
JSR Life Sciences Unveils Corporate Venture Fund
Aims to foster investment in new companies and innovative technologies.Charles Sternberg, Assistant Editor 03.24.21
-
Clinical Trials | CRO News | Information Technology
PPD, Clinical Ink Partner on Near Real-Time Access to Endpoint Data
Jointly develop systemic lupus erythematosus assessment review process to enhance data quality and research site personnel experiences and efficiencies.Kristin Brooks 03.24.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
BioCentriq and Kytopen Enter Cell Therapy Partnership
To show the impact to autologous and allogeneic cell therapies by integrating novel transfection technology with other steps in the manufacturing process.Tim Wright, Editor, Contract Pharma 03.23.21
-
Breaking News | Facilities | Industry News
Raybow Pharmaceutical Expands in U.S.
China-based CDMO will invest $15.8 million in North Carolina facility.Tim Wright, Editor, Contract Pharma 03.23.21
-
Breaking News | Collaborations & Alliances
Thermo Fischer Scientific Collaborates with Protein Metrics
Will facilitate precise, reliable mass spectrometry data processing and drive innovation for biopharmaceutical and proteomics applications.Charles Sternberg, Assistant Editor 03.22.21
-
Breaking News | Drug Development | Facilities | Industry News | Parenterals
Eisai Begins Construction of New Injection/Research Building
To accommodate expanded drug discovery targets and new modalities such as antibodies, ADCs, and nucleic acid drugs.Kristin Brooks 03.22.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Evotec, Takeda Enter Multi-RNA Target Alliance
To discover and develop small molecule therapeutics for highly attractive targets that are difficult to address via more conventional approaches.Kristin Brooks 03.22.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Fujifilm and Sana Biotechnology Enter Cell Therapy Partnership
Enter license agreement for the development of iPSC-derived cell therapies.Tim Wright, Editor, Contract Pharma 03.17.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Selexis, Pandion Enter Antibody Service Agreement
Pandion will leverage Selexis’ SUREtechnology Platform to advance an antibody targeting autoimmune and inflammatory diseases.Kristin Brooks 03.16.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Takeda and IDT Support Manufacturing of J&J’s COVID-19 Vaccine
Will make manufacturing capacity available at IDT’s facilities in Germany to manufacture the single-shot COVID-19 vaccine.Tim Wright, Editor, Contract Pharma 03.15.21
-
Clinical Trials | Information Technology
The Evolution of Clinical Research Technology to Support Remote Collaboration
Pioneering change with technology advancements that yield high reward with tolerable risk.Angela Gill Nelms, COO for Florence Healthcare 03.11.21
-
Breaking News | Collaborations & Alliances | Drug Development
Selexis SA and BITT Enter Service Agreement
Will develop the cell line for BITR2101, BITT’s lead tumor necrosis factor receptor 2 oncology candidate.Charles Sternberg, Assistant Editor 03.10.21
-
cGMP Manufacture | Process Development | Scale-up/Technology Transfer
Process Intensification: Understanding the Optimal Way to Maximize Productivity
Overcoming challenges of implementation and achieving increased volume, reduced timelines, decreased footprint, lower cost of goods, and increased flexibility.Priyanka Gupta, Head of Market Entry Strategy for Protein Based Therapeutics, Sartorius 03.09.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Celonic to Boost Cell & Gene Therapy Production
Will establish a new facility in the upcoming Life Science Park Rheintal in Stein, Switzerland.Tim Wright, Editor, Contract Pharma 03.05.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie
Continues to build integrated capabilities platform for cell and gene therapy.Tim Wright, Editor, Contract Pharma 03.05.21
-
Breaking News | Collaborations & Alliances | Drug Delivery | Industry News
Aptamer Extends Collaboration with AstraZeneca
Will continue to explore next-generation drug delivery approaches.Tim Wright, Editor, Contract Pharma 03.05.21
-
Information Technology
5 Reasons Paper Has No Place in Contract Manufacturing
Digital solutions create more efficient manufacturing processes and eliminate delays.Dave Edwards, Chief Revenue Officer, MasterControl 03.01.21
-
Cold Chain Management | Logistics | Packaging & Tracking | Supply Chain
Reshaping the Pharmaceutical Supply Chain
The pandemic and COVID-19 vaccines bring navigating the cold-chain and preserving precious biologics to the forefront.Kristin Brooks, Managing Editor 03.01.21
-
Breaking News | CRO News | Drug Discovery | Industry News | R&D
Icon to Acquire PRA Health Sciences
Brings together two organizations to create a leading healthcare intelligence and clinical CRO.Charles Sternberg, Assistant Editor 03.01.21
-
Breaking News | Collaborations & Alliances | Industry News
Phlow Corp. and USP Form Alliance
Focused on continuous manufacturing to increase supply of essential medicines for U.S. patients.Tim Wright, Editor, Contract Pharma 03.01.21
-
Breaking News | Facilities | Industry News | Solid Dosage/Creams/Ointments
Novo Nordisk Invests $80M in Tablet Production
Expanding site in Måløv, Denmark that currently makes oral products to treat diabetes.Tim Wright, Editor, Contract Pharma 03.01.21
-
Breaking News | Promotions & Moves
Spark Therapeutics Appoints CTO
Cynthia Pussinen will oversee manufacturing and technical operations, including pipeline process development, preclinical and clinical manufacturing.Kristin Brooks 02.26.21
-
Bio News | Breaking News | Industry News
High Purity New England Bolsters Biopharma Solutions Services
Launches customizable cell culture bioreactor line.Tim Wright, Editor, Contract Pharma 02.25.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
AMRI Contributes to Efforts to Increase COVID-19 Vax Supply
Joins network of approved manufacturers of lipid excipients for Pfizer-BioNTech COVID-19 vaccine.Tim Wright, Editor, Contract Pharma 02.25.21
-
Analytical Services | Breaking News | Drug Discovery | Facilities | Industry News | R&D
CatSci Opens New Site in UK
Strengthens analytical capabilities with the opening of a secondary site in Dagenham backed by a $4.2 million investment.Tim Wright, Editor, Contract Pharma 02.25.21
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News | Solid Dosage/Creams/Ointments
Pfizer Partners with Medicines Manufacturing Innovation Center
To transform the formulation of oral solid dosage medicines.Tim Wright, Editor, Contract Pharma 02.25.21
-
Bioanalytical Services | Breaking News | Industry News | Preclinical Outsourcing
Altasciences Contributes to Vibegron Approval
Provided clinical support for two drug-drug interaction studies and a bioavailability trial for the overactive bladder treatment.Kristin Brooks 02.24.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Information Technology
Pfizer Selects Seven Bridges to Support RNA Sequencing Data
Seven Bridges will centralize and manage terabytes scRNASeq data, which provides detailed analysis of gene expression in individual cells.Kristin Brooks 02.24.21
-
Analytical Services | Breaking News | Facilities | Industry News | Laboratory Testing
ACG Launches ACG Laboratories
Opens a process development lab in Shirwal, India.Tim Wright, Editor, Contract Pharma 02.23.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
Catalent Acquires Delphi Genetics
Launches US plasmid manufacturing site to establish global pDNA development and manufacturing capabilities.Tim Wright, Editor, Contract Pharma 02.23.21
-
Analytical Services | Bioanalytical Services | Breaking News | Chemistry | Facilities | Industry News | Laboratory Testing | R&D
Almac Group Completes $7M R&D Center
Significant expansion of biocatalysis, flow chemistry, and peptide capacity.Tim Wright, Editor, Contract Pharma 02.23.21
-
Breaking News | Drug Development | Promotions & Moves
Aevitas Therapeutics Appoints President and CEO
Dr. Markus Peters offers a 25-year track record of developing and commercializing orphan and specialty pharmaceuticals.Charles Sternberg, Assistant Editor 02.22.21
-
Breaking News | CRO News | Industry News
Eurofins Scientific Acquires Beacon Discovery
Expands its integrated drug discovery capabilities and expertise.Charles Sternberg, Assistant Editor 02.19.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Intravacc Unveils New Pilot Vaccine Production Facility
State-of-the-art pilot plant for production of vaccine candidates in clinical phase I & II research.Tim Wright, Editor, Contract Pharma 02.19.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Century Therapeutics Significantly Expands Capabilities
Unveils new operational, laboratory and manufacturing facilities in Pennsylvania and New Jersey.Tim Wright, Editor, Contract Pharma 02.19.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Charles River Acquires CDMO Cognate BioServices
Pays roughly $875 million to significantly expand capabilities in the cell and gene therapy sector.Tim Wright, Editor, Contract Pharma 02.17.21
-
Biologics, Proteins, Vaccines | Collaborations & Alliances | Drug Development
Molecular Templates, BMS Enter Strategic Research Pact
Aims to discover and develop multiple therapies for specific oncology targets utilizing MTEM’s next-gen engineered toxin body (ETB) platform.Kristin Brooks 02.11.21
-
Breaking News | Facilities | Industry News
Scapa Healthcare Enhances OTC Drug Manufacturing Capabilities
Makes multimillion dollar investment at its Knoxville facility.Tim Wright, Editor, Contract Pharma 02.10.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
AbbVie, Caribou Ink CAR-T Collaboration
Leverages Caribou's next-generation CRISPR genome editing technology platform and AbbVie's antigen-specific binders.Tim Wright, Editor, Contract Pharma 02.10.21
-
Breaking News | Collaborations & Alliances | CRO News | Drug Discovery | Industry News | R&D
Jubilant Biosys, Yale Form Research Alliance
Aims to accelerate small molecule discovery programs leveraging Jubilant's medicinal chemistry, structural biology, in-vitro and in-vivo pharmacology.02.10.21
-
Promotions & Moves
Lilly Apoints SVP, CFO
Anat Ashkenazi replaces Josh Smiley, who has resigned and will be leaving the company.Kristin Brooks 02.09.21
-
Biologics, Proteins, Vaccines | Breaking News
RotaChrom Technologies Partners with Cyclolab
Aims to develop a more efficient and cost-effective process to purify Remdesivir, a widely used treatment option for COVID-19.Charles Sternberg, Assistant Editor 02.09.21
-
Breaking News | Industry News | Promotions & Moves
AMRI Makes Executive Move
Appoints Scott Waldman to lead corporate development.Tim Wright, Editor, Contract Pharma 02.08.21
-
Breaking News | CRO News | Industry News
Anova Enterprises Acquires Corlexia Clinical Services
Adds further depth and experience to the Anova leadership team.Charles Sternberg, Assistant Editor 02.08.21
-
Breaking News | Industry News
TCG Lifesciences Expands Footprint to the U.S.
Establishes CDMO subsidiary TCG GreenChem in New Jersey and Virginia.Tim Wright, Editor, Contract Pharma 02.08.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Paragon Biosciences Expands Cell and Gene Therapy Platform
Launches CiRC Biosciences with an initial focus on developing eye disease treatments.Tim Wright, Editor, Contract Pharma 02.08.21
-
Biologics, Proteins, Vaccines | Clinical Trials
Inside a COVID Vaccine Trial
Dr. Murphy of ICON, provider of clinical services to Pfizer/BioNTech’s COVID vaccine program, discusses what it takes to conduct a vaccine trial of this scale.Kristin Brooks, Managing Editor 02.05.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
CureVac, UK Partner on Vaccines Against SARS-CoV-2 Variants
Aims to mitigate the effects of the pandemic and help prepare against future SARS-CoV-2 outbreaks by working on multiple variant vaccines.Kristin Brooks 02.05.21
-
Industry News
Sepha Launches Small Batch Contract Packaging Service
Aims to provide cost-effective, low volume runs of blister and medical device packs within short turnarounds.Kristin Brooks 02.05.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
J&J Submits EUA for Single-Shot Janssen COVID Vax Candidate
Plans to distribute vaccine to U.S. government immediately following authorization, and expects to supply 100 million doses in 1H21.Kristin Brooks 02.05.21
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development
The Future of Vaccines and Biologics
Dr. Linda Marbán of Capricor Therapeutics discusses the advances in responding to infectious diseases.Kristin Brooks, Managing Editor, Contract Pharma 02.04.21
-
Breaking News | Clinical Trials | Drug Development | Industry News
Affimed, Roche Explore AFM24, Tecentriq Combo
To investigate the combination for the treatment of advanced solid epidermal growth factor receptor (EGFR) expressing malignancies.Kristin Brooks 02.03.21
-
Breaking News | Collaborations & Alliances | Drug Development
Imcyse, Pfizer Enter Autoimmune Research Alliance
Will develop Imotope candidates to potentially treat Rheumatoid Arthritis.Charles Sternberg, Assistant Editor 02.03.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Drug Development | Industry News
Immunome, Abzena Enter COVID-19 Antibody Cocktail Agreement
Abzena will work with Immunome to produce the antibody cocktail for clinical testing.Kristin Brooks 02.03.21
-
Breaking News | Drug Development | Industry News
Lilly Acquires Asahi Kasei’s Chronic Pain Candidate
To pay $20 million upfront and up to $210 million in potential milestones for AK1780, an orally bioavailable P2X7 receptor antagonist.Kristin Brooks 02.01.21
-
Breaking News | Drug Development | Industry News
Gilead, Gritstone Enter Vax Platform Pact for HIV Cure
Aims to develop HIV-specific vaccine using Gritstone’s prime-boost vaccine platform with antigens developed by Gilead.Kristin Brooks 02.01.21
-
Cold Chain Management | Logistics | Supply Chain
Delivering Custom Client Solutions
Cold chain solutions provider Sentry BioPharma Services is able to adapt to meet the diverse needs of its clients.Contract Pharma Staff
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Drug Discovery | Industry News | Information Technology
Evozyne, Takeda Ink Strategic Protein Design Agreement
Takeda will use Evozyne's evolution-based protein design technology to research and develop proteins for next-gen gene therapies.Kristin Brooks 01.28.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Lonza Launches Cryopreserved Leukopaks
Customizable cryopreserved Leukopaks aim to provide greater flexibility in immunology and cell therapy research.Kristin Brooks 01.28.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Valneva Begins COVID Vax Production to Optimize Potential Deliveries
Inactivated, adjuvanted COVID-19 vaccine candidate is in Phase 1/2 clinical development with initial results in April 2021.Kristin Brooks 01.28.21
-
Parenterals
Parenteral Drug Delivery Trends
A Q&A with Lubrizol Life Science Health’s CDMO Division President, Rob Lee.Kristin Brooks, Managing Editor, Contract Pharma 01.27.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies
Lilly expands BLAZE-4 trial to evaluate bamlanivimab with VIR-7831, two neutralizing antibodies that bind to different epitopes of the SARS-CoV-2 spike protein.Kristin Brooks 01.27.21
-
Clinical Trials | Information Technology
The State of Clinical Trial Technology
Blake Adams of Florence discusses key report findings and the clinical trial software used to support Pfizer’s global COVID-19 vaccine study.Kristin Brooks, Contract Pharma 01.26.21
-
Clinical Trials
The Future of Clinical Trials Series: Part II
Greater awareness will ensure diversity is no longer an afterthought and patients will be at the center of every aspect of clinical research.Jena Daniels, Rasmus Hogreffe, Ingrid Oakley-Girvan, Dr. Michelle Longmire, Medable 01.26.21
-
Breaking News | Collaborations & Alliances
BioMed X, Janssen Enter Oral Drug Delivery Alliance
Aims to discover novel transport mechanisms which could be utilized for oral delivery of therapeutic modalities.Charles Sternberg, Assistant Editor 01.26.21
-
Breaking News | Clinical Trials | Industry News
Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial
Care Access to provide decentralized, mobile research site operations for AstraZeneca’s AZD7442 Phase III trial in the U.S.Kristin Brooks 01.26.21
-
Breaking News
500+ Sites Join Inato’s Industry Marketplace
Platform aims to make clinical research more inclusive and efficient.Charles Sternberg, Assistant Editor 01.26.21
-
Breaking News | cGMP Manufacture | Excipients | Industry News
PromoCell Receives EXCiPACT Certification
Manufactures pharmaceutical excipients to GMP standards for tailor-made cell culture media and reagents that fulfill specific regulatory requirements.Kristin Brooks 01.26.21
-
Breaking News | Facilities | Industry News | Injectables | Parenterals
Civica to Build an Essential Medicines Manufacturing Facility in Virginia
Will produce sterile injectable meds used in hospitals for COVID-19 patient care.Tim Wright, Editor, Contract Pharma 01.25.21
-
Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Humanigen, Emergent Enter Covid-19 Partnership
Sign contract development and manufacturing agreement for Phase 3 COVID-19 therapeutic candidate lenzilumab.Tim Wright, Editor, Contract Pharma 01.25.21
-
Breaking News | Promotions & Moves
Eisai Appoints Chief Clinical Officer of Oncology Biz
Dr. Richard Woodman has 18 years of pharmaceutical experience in several different functional areas at both large and small biotech organizations.Contract Pharma Staff 01.20.21
-
Clinical Trials
The Future of Clinical Trials Series: Part I
What will 2021 have in store for an industry in flux?Alison Holland, Head of Decentralized Trials, Medable, Maria Fotiu, Executive Vice President of Decentralized Solutions, Syneos Health 01.19.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
Intravacc Completes Project for Provention Bio’s Vax Candidate
Potentially the first preventive vaccine for coxsackievirus B, a risk factor associated with type 1 diabetes and celiac disease.Contract Pharma Staff 01.19.21
-
Breaking News | Collaborations & Alliances | Drug Discovery
Metrion, LifeArc Extend Neuroscience Alliance
Collaboration extended for another 12 months after successfully progressing into late stage hit-to-lead optimization phase.Contract Pharma Staff 01.18.21
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Janssen, TenNor Enter NTM Research Pact
To leverage TenNor’s multitargeting drug conjugation platform to discover new therapies to treat nontuberculous mycobacteria diseases.Contract Pharma Staff 01.18.21
-
Clinical Trials | Drug Development | Information Technology
Virtual Clinical Trials: The Future of Dermatology Studies
COVID-19 has created lasting impacts for clinical trials and a host of benefits have arisen from the adoption of virtual and hybrid models.Sonja VanWye, RN, MSN, Director, Dermatology Strategy, IQVIA Biotech 01.15.21
-
Breaking News | Collaborations & Alliances | CRO News | Industry News
Bioclinica Partners with Ikcon Pharma
Will work together to deliver best-in-class e-clinical solutions to the pharma industry & sponsors.Contract Pharma Staff 01.15.21
-
Breaking News | Clinical Trials | CRO News | Industry News
Frontage Bolsters Clinical Services Capabilities
Unveils plans to provide full service human radiolabeled absorption, metabolism, and excretion study capabilities.Contract Pharma Staff 01.15.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Precision Medicine Group Acquires Project Farma
Adds Project Farma's unique expertise to Precision's suite of end-to-end cell and gene therapy capabilities to support development and commercialization.Contract Pharma Staff 01.14.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center
FUJIFILM Diosynth Biotechnologies will provide GMP contract process development and manufacturing services as part of its role in the new center.Contract Pharma Staff 01.14.21
-
The Dedicated Center
Outsourcing answer to the innovation and ROI challenge in the Biopharmaceutical Industry.
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Almac Sciences Secures Support from Invest NI
Accelerates enzyme discovery program.Contract Pharma Staff 01.13.21
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Delivery | Facilities | Industry News | Solid Dosage/Semi-solids
Catalent Acquires Acorda’s INBRIJA Manufacturing Operations
The CDMO pays $80 million for dry powder inhaler spray drying, capsule manufacturing and packaging operations in Boston area.Contract Pharma Staff 01.13.21
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Cyclolab and EpiPharma Form Joint Venture
Will develop and commercialize Peptide drug candidates for the treatment of debilitating CNS and Pulmonary diseases.Contract Pharma Staff 01.11.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production
Texas A&M System contract designates the CDMO’s Texas facility for emergency federal use.Contract Pharma Staff 01.11.21
-
Clinical Trials | CRO News
Caprion-HistoGeneX Acquires Clinical Logistics
Expands its support of clinical trials specimen logistics.Contract Pharma Staff 01.08.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Laboratory Testing
Biohaven Acquires Remaining Stake in Kleo Pharmaceuticals
Enters exclusive license agreement with Yale University for a novel extracellular degrader technology licensed from Spiegel Lab.Contract Pharma Staff 01.08.21
-
Promotions & Moves
Ionis Appoints Clinical Development EVP
Eugene Schneider will oversee clinical development of novel antisense medicines across all of Ionis' therapeutic franchises.Contract Pharma Staff 01.08.21
-
The Changing R&D Landscape
Emerging Technology Needs and Value Proposition for Strategic Partnerships with Contract Development and Manufacturing Organizations (CDMOs)
-
APIs | Breaking News | cGMP Manufacture | Facilities | Industry News
AmbioPharm Opens New Shanghai Campus
Adds European executive team members working out of new Zurich office.Contract Pharma Staff 01.07.21
-
Clinical Trials | Drug Development
The Slow – But Desperately Needed – Evolution of Oncology Clinical Development Designs
Appropriate adaptive designs in early stages of development can accelerate timelines and reduce costs, and help focus on the most promising agents.Jürgen Hummel, MSc, Senior Director, Statistical Science, PPD, and Lead of PPD’s Adaptive Design Working Group 01.07.21
-
Breaking News
Bioclinica Acquires Saliency
Integrates the company's advanced AI technology into its Imaging Platform.Contract Pharma Staff 01.06.21
-
Breaking News | Clinical Trials | Promotions & Moves
Parexel Appoints Chief Patient Officer
Demonstrates the company’s commitment to elevating the patient perspective.Contract Pharma Staff 01.06.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
Genezen Laboratories Receives Growth Equity Investment
Will fund the completion of the company’s lentiviral vector production facility.Contract Pharma Staff 01.05.21
-
RTP Laboratory
...
-
-
Breaking News | Promotions & Moves
Natoli Engineering Appoints Northeast Service Technician
Hires Danny Yadram Chandarballi for the position.Contract Pharma Staff 12.18.20
-
Abenza Promotes Kimball Hall to President
Hall also joins the Company Board.Contract Pharma Staff 12.18.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Thermo Fisher Expands Plasmid DNA Mfg. Capabilities
New 67,000-square-foot Carlsbad, CA cGMP site will accelerate commercialization of plasmid-based medicines and vaccines.Contract Pharma Staff 12.17.20
-
Bioanalytical Services | Breaking News | cGMP Manufacture | Industry News
Passage Bio Invests in Gene Therapy Manufacturing R&D Site
In combination with dedicated cGMP suite at Catalent, the new lab creates foundation for integrated AAV gene therapy manufacturing.Contract Pharma Staff 12.17.20
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Evotec, BMS Advance Targeted Protein Degradation Projects
The first two targets transition into drug discovery after completing a comprehensive target validation process.Contract Pharma Staff 12.17.20
-
Bio News | Breaking News | Industry News | Promotions & Moves
Samsung Biologics Names John Rim as President and CEO
Prior to being named chief executive, Rim was executive vice president at the Korea-based CDMO for the past three years.Contract Pharma Staff 12.16.20
-
Bio News | Bioanalytical Services | Bioassay Development | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Collaboration Creates Bio Hub in Northern UK
CDMO Fujifilm Diosynth Biotechnologies is part of Northern Bio-Accelerator Partnership.Contract Pharma Staff 12.16.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Information Technology | QA/QC
CDMO Cognate BioServices Teams Up with L7 Informatics
To implement L7|ESP for integrated manufacturing and lab operations.Contract Pharma Staff 12.16.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
INOVIO to Develop dMAb COVID Treatments under DARPA Grant
$37.6 million grant will leverage AstraZeneca's monoclonal antibody and INOVIO's dMAb technologies in the fight against COVID-19.Contract Pharma Staff 12.15.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Lilly to Acquire Prevail Therapeutics in $1B Deal
Adds a new drug discovery and development modality and creates a gene therapy program anchored by Prevail's portfolio of neuroscience assets.Contract Pharma Staff 12.15.20
-
Breaking News | Industry News
AstraZeneca to Acquire Alexion in $39B Deal
Expands scientific presence in immunology by adding Alexion's innovative complement-technology platforms and strong pipeline, and top seller Soliris.Contract Pharma Staff 12.14.20
-
Clinical Trials | Drug Development | Information Technology
Advancing Digital Endpoints in Clinical Trials
An end-to-end approach to managing wearable devices through clinical development.Kristin Brooks, Contract Pharma 12.14.20
-
Clinical Trials | Information Technology
Life Sciences Strive for Greater Agility
Embracing real-time drug safety monitoring during and post COVID will continue to propel the industry forward.Ronan Brown, SVP of Integrated Technology & Compliance, and Joe Rymsza, VP, Global PV & Regulatory Technology Solutions, IQVIA 12.14.20
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Boehringer to Acquire NBE-Therapeutics in €1.2B Transaction
Gains iADC platform and potential best-in-class antibody-drug conjugate (ADC) therapies for the treatment of solid tumors.Contract Pharma Staff 12.10.20
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Initium Therapeutics Launches Antibody Development Platform
Expands its antibody drug pipeline using GenScript Bio’s Berkeley Lights Beacon platform.Contract Pharma Staff 12.09.20
-
Breaking News | CRO News | Industry News | R&D
LINK Medical Acquires IRW Consulting AB
Strengthens its position in the Nordics while improving its offerings and capabilities.Contract Pharma Staff 12.09.20
-
Breaking News | Industry News | R&D
Colorcon Ventures Invests in i20 Therapeutics
Will work together to accelerate i2O’s research and development efforts.Contract Pharma Staff 12.07.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Lilly, UnitedHealth to Study Bamlanivimab in High-risk COVID-19
The study will identify and treat a large, diverse population of high-risk individuals for COVID-19 with bamlanivimab under real-world conditions.Contract Pharma Staff 12.04.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Batavia Biosciences and KU Leuven Join Forces
Will accelerate the development of a highly promising Covid-19 vaccine candidate.Contract Pharma Staff 12.03.20
-
Breaking News | Drug Development | Promotions & Moves
NeuBase Therapeutics Appoints Chief Scientific Officer
Dr. Curt Bradshaw brings decades of experience in successfully delivering genetic medicines to clinics.Contract Pharma Staff 12.02.20
-
Bioanalytical Services | Breaking News | cGMP Manufacture | Industry News
KBI Biopharma Expands U.S. Ops
Invests $150 million in commercial biologics manufacturing facility in RTP, NC.Contract Pharma Staff 12.02.20
-
Embion, Asahi Group Enter Strategic Collaboration
Plan to develop new products from brewing by-products generated by Asahi Group.Contract Pharma Staff 12.01.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
CDMO Stelis Continues Expansion
Starts next phase of investment into its biologics manufacturing facility.Contract Pharma Staff 12.01.20
-
Breaking News | Drug Development | Formulation Development | Industry News
Vectura, Kinaset Partner to Develop Asthma Treatment
Licenses VR588 to Kinaset, Vectura will provide formulation development services to support Phase I studies and ultimately commercialization.Contract Pharma Staff 11.30.20
-
Breaking News | Clinical Trials | Industry News
SGS Initiates U.S. COVID-19 Clinical Trials
Phase 2/3 trial will examine the safety, tolerability, and efficacy of Sarconeos (BIO101) to treat COVID-19 related respiratory failure.Contract Pharma Staff 11.30.20
-
-
Breaking News | Facilities | Industry News | Injectables | Parenterals
ApiJect Systems Approved for $590 Million Loan
Supports building a U.S.-based facility with surge capacity to produce up to 3 billion single-dose prefilled plastic injectors per year.Contract Pharma Staff 11.24.20
-
Breaking News | Facilities | Industry News
Abenza Upgrades Chemistry GMP Suites
Appoints new leadership at Bristol PA site.Contract Pharma Staff 11.24.20
-
Breaking News | Clinical Trials | Industry News
Merck Acquires OncoImmune for $425M
Acquisition adds to Merck’s suite of clinical programs in response to SARS-CoV-2/COVID-19.Contract Pharma Staff 11.24.20
-
Breaking News | Drug Development | Trials & Filings
Regeneron's COVID-19 Antibody Cocktail Gets EUA
Expects to have treatment doses ready for approximately 80,000 patients by the end of November, and 200,000 by the first week of January.Contract Pharma Staff 11.23.20
-
Breaking News | Promotions & Moves
Summit Therapeutics Appoints Chief Operating Officer
Dr. Mahkam Zanganeh previously founded and led Maky Zanganeh and Associates consulting services firm.Contract Pharma Staff 11.23.20
-
Breaking News | Collaborations & Alliances | Drug Development
Amgen Ends Cardio Alliance with Cytokinetics
Will transition the development and commercialization rights for omecamtiv mecarbil to Cytokinetics and Servier.Contract Pharma Staff 11.23.20
-
Breaking News | Industry News | Promotions & Moves
Frontida BioPharma Appoints EVP Technology
Dr. Praful Agrawala brings years of pharmaceutical product development leadership experience to the company.Contract Pharma Staff 11.20.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
Pfizer and BioNTech to Submit EUA for COVID-19 Vaccine
Expect to produce globally up to 50 million doses in 2020, up to 1.3 billion doses by the end of 2021; ready to distribute within hours after authorization.Contract Pharma Staff 11.20.20
-
Collaborations & Alliances | Drug Development
Cue Biopharma, Merck Extend Biologics Research Alliance
To develop clinical candidate for the treatment of type 1 diabetes and an additional undisclosed autoimmune disease.Contract Pharma Staff 11.19.20
-
Biologics, Proteins, Vaccines | Industry News
Avantor Opens New Biorepository Facility in Europe
Supports growing demand for scientific research and clinical trial sample storage.Contract Pharma Staff 11.19.20
-
Breaking News | CRO News | Facilities | Industry News
SGS Plans to Move Its Clinical Pharmacology Unit
Increases its capacity to conduct Human Challenge studies.Contract Pharma Staff 11.18.20
-
Cell & Gene Therapy Supply Chain: Early Preparation is Key
Supply chain management for cell and gene therapies requires precise demand planning and forecasting.Matthew Farabaugh, Chief Financial Officer, The Discovery Labs 11.17.20
-
Clinical Trials | Information Technology | R&D
Decentralized Trials Fuel AI Revolution in Clinical Research
The life sciences industry is giving clinical a full makeover, dramatically improving how new therapeutics are developed.Nick Moss, Vice President of Analytics and Machine Learning, Medable 11.17.20
-
Breaking News
Syneos Health Appoints Chief Information & Digital Officer
Larry A. Pickett brings 30 years of relevant experience.Contract Pharma Staff 11.17.20
-
Bioassay Development | Biologics, Proteins, Vaccines | Drug Development | Facilities
Opportunities in Synthetic Biology
Les Tillack, CEO of Luina Bio, discusses how ‘synbio’ is driving growth in the biopharma industry.Contract Pharma Staff
-
Breaking News | Collaborations & Alliances | Industry News
Lead Pharma and Roche Enter Collaboration & License Agreement
Will develop oral small molecules to treat immune mediated diseases.Contract Pharma Staff 11.16.20
-
Clinical Trials | Information Technology
eCOA: Addressing Barriers to Faster Deployment in Clinical Trials
Clinical Outcome Assessments are an increasingly important tool in clinical research.Paul O'Donohoe, Scientific Lead, eCOA and Mobile Health, Medidata 11.13.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture
CCRM, MIP Partner to Build Biomanufacturing Campus
Aims to establish CDMO ops focused on regenerative medicine-based technologies and cell and gene therapies.Contract Pharma Staff 11.13.20
-
-
Breaking News | Industry News
TCR² Therapeutics, ElevateBio Expand TC-210 Mfg. Capacity
Strategic partnership will leverage technical capabilities at ElevateBio for the production of TC-210 to support Phase II clinical trial.Contract Pharma Staff 11.11.20
-
Breaking News | CRO News | Industry News | Information Technology
RhoFED Wins BARDA Contract
Will serve to standardize data collection, management, and analysis across BARDA-supported network studies.Contract Pharma Staff 11.10.20
-
Breaking News | CRO News | Drug Discovery | Industry News
MercachemSyncom Acquires Admescope
Significantly expands its capabilities for in vitro and in vivo studies.Contract Pharma Staff 11.10.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Facilities | Industry News
Novavax Expands Facility to Support Global Vaccine Development
Expands campus with two properties to support vaccine research and development, manufacturing, business operations.Contract Pharma Staff 11.10.20
-
Bioassay Development | Breaking News | Industry News
GenScript Gets EUA for SARS-CoV-2 Neutralizing Antibody Detection Kit
cPass SARS-CoV-2 Neutralization Antibody kit is the only EUA authorized virus-free testing assay that detects neutralizing antibodies within an hour.Contract Pharma Staff 11.10.20
-
Breaking News | Drug Development | Promotions & Moves
Inozyme Pharma Appoints SVP, Regulatory Affairs
Dr. Kevin B. Johnson brings over 25 years of experience to the role.Contract Pharma Staff 11.09.20
-
Bio News | Breaking News | Collaborations & Alliances | Industry News | Packaging & Tracking | Promotions & Moves
Contract Pharma Audience Survey
Take a minute to answer a few questions and you could win a $100 Visa gift card!Contract Pharma Staff 11.06.20
-
Breaking News | Collaborations & Alliances | Industry News
AMRI Named Exclusive API Supplier for Recently Approved Acne Treatment
FDA approved Cassiopea’ Winlevi cream 1% in August 2020.Contract Pharma Staff 11.06.20
-
Breaking News | CRO News | Industry News
ACG Acquires Significant Stake in IQGEN-X
Enables IQGEN-X to fast-track research on existing ANDAs and set up another cGMP pilot facility.Contract Pharma Staff 11.05.20
-
Financial Reports
Financial Report: Merck
Pharmaceutical sales were up 2% to $11.3 billion in the quarter, driven primarily by growth in oncology and certain hospital acute care products.Contract Pharma Staff 11.04.20
-
Excipients
Pharmaceutical Excipients Market Poised for Growth
The global pharmaceutical excipients market is estimated to surpass $11,944.6 million by 2027.Contract Pharma Staff 11.03.20
-
Bio News | Breaking News | Facilities | Industry News
Crown Biosciences Opens Facility in China
Full operational capacity is expected in early 2021.Contract Pharma Staff 11.03.20
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News
Sensorion and Novasep Sign Agreement
Covers the development and manufacturing of AAV vectors, a key step for Sensorion’s gene therapy programs.Contract Pharma Staff 11.03.20
-
-
Working with Clinical Research Sites: Strategic Planning and Operations for Sponsors and CROs
...11.03.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Sanofi to Acquire Kiadis for $359M
Adds next-gen natural killer cell platform and pipeline of cell-based cancer immune-therapeutics and infectious disease therapies.Contract Pharma Staff 11.03.20
-
Breaking News | CRO News | Facilities | Industry News | R&D
Reach Separations Expands Nottingham Premises
Responds to increased demand for its chiral purification services.Contract Pharma Staff 11.03.20
-
Bio News | Breaking News | cGMP Manufacture | Industry News
eTheRNA Extends mRNA Production Services
Adds high throughput research grade mRNA to its GMP capabilities.Contract Pharma Staff 11.03.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Novartis Expands Kymriah Manufacturing Footprint
Gets green light for commercial CAR-T cell therapy manufacturing site in Asia.Contract Pharma Staff 11.03.20
-
cGMP Manufacture | Fill/Finish | Scale-up/Technology Transfer
Ramping Up COVID-19 Vaccine Fill and Finish Capacity
As a partner to the U.S. Government, GRAM's newest facility was designed to increase large-scale fill and finish capacity with room to expand as demand grows.Kristin Brooks, Contract Pharma 11.03.20
-
Bio News | Breaking News | Drug Development | Facilities | Industry News
-
Breaking News
Syneos Health Agrees to Acquire Synteract
Enhances Syneos Health’s position across the fast-growing small to mid-sized category.Contract Pharma Staff 10.29.20
-
Bioanalytical Services | Breaking News | CRO News | R&D
TherapeutAix Expands R&D Network
Adds CROs Alderley Analytical and Peak Proteins to address Pharmacokinetics and Pharmacodynamics challenges for clients.Contract Pharma Staff 10.29.20
-
Breaking News | Clinical Trials | CRO News
BARDA Reselects ICON as Preferred Partner
Continues as part of BARDA’s exclusive Medical Countermeasures Clinical Studies NetworkContract Pharma Staff 10.29.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Bayer to Pay up to $4B for Gene Therapy Firm AskBio
Purchase includes an established CDMO, lays the foundation for future partnerships in the area of AAV therapies.Contract Pharma Staff 10.28.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | R&D
Sai Life Sciences to Expand Biology Capabilities
Begins construction of new 75,000 sq. ft. facility in Hyderabad; adding 170 biologists to team.Contract Pharma Staff 10.28.20
-
Breaking News | Collaborations & Alliances | Facilities | Industry News
Construction Starts on the Medicines Manufacturing Innovation Center
Will offer next-gen solutions in small molecule and pharmaceutical manufacturing.Contract Pharma Staff 10.26.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News
Moderna Completes Enrollment in Phase III COVID-19 Vax Study
COVE study designed in collaboration with the FDA and NIH to evaluate Americans at the highest risk of severe COVID-19 disease in 30,000 participants.Contract Pharma Staff 10.22.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances
Kamada Signs Supply Agreement with Israeli Health Authorities
Will provide investigational Covid-19 plasma-derived Immunoglobulin.Contract Pharma Staff 10.22.20
-
Breaking News | Collaborations & Alliances | Industry News
Lubrizol Expands Partnership with the Population Council
Will develop a contraceptive vaginal system for protection against unintended pregnancy.Contract Pharma Staff 10.21.20
-
Breaking News | Industry News | Promotions & Moves
Metrics Contract Services Expands Business Development Team
Names Lettie Kirk as business development executive.Contract Pharma Staff 10.21.20
-
Biologics, Proteins, Vaccines
India Emerges as Hot Spot for Manufacturing COVID-19 Vaccines
CMOs expand and ‘repurpose’ capacities.S Harachand, Contributing Editor 10.20.20
-
Clinical Trials | Drug Development | Preclinical Outsourcing
Accelerating R&D Trends
The pandemic has propelled lingering trends into the forefront and increasingly complex molecules and biologics have drug developers outsourcing more.Kristin Brooks, Contract Pharma 10.20.20
-
Breaking News | Clinical Trials
CNS Pharmaceuticals Completes U.S. Manufacturing of Berubicin
Phase 2 trial will commence during the first quarter of 2021.Contract Pharma Staff 10.20.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
CEVEC, Rznomics Ink License Agreement for CAP Technology
Rznomics will use CEVEC’s cell line technology with its trans-splicing ribozyme technology for manufacturing gene therapies targeting various cancers.10.20.20
-
Bio News | Breaking News | Facilities | Industry News | Parenterals
INCOG BioPharma Launches Central Indiana Ops
New CDMO is investing roughly $60 million to construct and equip a 60,000-square-foot facility in Fishers.Contract Pharma Staff 10.19.20
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Antegene, WuXi Biologics Enter Oncology R&D Alliance
To collaborate on the development and production of novel drugs, and jointly promote the R&D of innovative oncology therapies in China.Contract Pharma Staff 10.19.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Rentschler Biopharma and ATUM Ink Licensing Agreement
Leap-In Transposase technology will be integrated into Rentschler’s in-house process to complement existing CLD offering.Contract Pharma Staff 10.15.20
-
Clinical Trials | Information Technology
The Role of Electronic Monitoring in Maintaining Medication Adherence
Digital solutions offer hope to get patients to take their medications properly.Bernard Vrijens, Scientific Lead, AARDEX Group 10.14.20
-
Aseptic Processing | Fill/Finish
A Holistic Cleanroom Concept: Higher Quality and Greater Flexibility
Overcoming today’s aseptic fill-and-finish process challenges.Ute Schleyer, Project Manager, Site & Plant Development, Vetter 10.14.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Dyno, Roche Ink Gene Therapy Deal Worth up to $1.8B
Collaboration combines Dyno’s AI-powered AAV vector capabilities with Roche and Spark Therapeutics’ gene therapy capabilities.Contract Pharma Staff 10.14.20
-
Analytical Services | Bioanalytical Services | Breaking News | Industry News | Laboratory Testing
PPD to Open Multipurpose Clinical Research Lab in Suzhou
Will offer bioanalytical, biomarker and vaccine services for global and China-based biopharma customers.10.14.20
-
Breaking News | Collaborations & Alliances | Industry News | Information Technology
U.S. Govt. Selects LabVantage’s LIMS
Walter Reed Army Research Inst. will use LIMS to support the production of vaccines for COVID-19 and other diseases.Contract Pharma Staff 10.13.20
-
Breaking News | Collaborations & Alliances | Industry News
BryoLogyx Completes World’s First GMP Synthesis of Bryostatin-1
Partnered with CDMO AMRI for GMP synthesis.Contract Pharma Staff 10.13.20
-
Clinical Trials | Information Technology
Adding Remote Site Access to Sponsor Bids: What to Know as CRO
Traditional monitoring has changed, CROs should build a portfolio of remote access solutions and have them ready.Ryan Jones, CEO, Florence Healthcare 10.13.20
-
Drug Delivery
Topical Drugs Poised for Growth
The topical drug delivery market is projected to reach $129.8 billion by 2025 from $95.2 billion in 2020, at a CAGR of 6.4%.Contract Pharma Staff 10.12.20
-
Drug Delivery
Drug Delivery Market Report
The pharmaceutical drug delivery market was valued at $1,403,082.9 million in 2019 and is projected to reach $2,296,170.9 million by 2027.Contract Pharma Staff 10.12.20
-
cGMP Manufacture | Drug Development | Promotions & Moves
AGC Biologics Appoints New GM of Milan Site
Luca Alberici will initiate integration efforts resulting from the July 2020 acquisition of MolMed.Contract Pharma Staff 10.12.20
-
Breaking News | Collaborations & Alliances | Drug Development | R&D
Antengene, WuXi Biologics Ink Innovative Oncology R&D Alliance
Partner for the development and production of novel drugs, and to jointly promote R&D of innovative oncology therapies.Contract Pharma Staff 10.12.20
-
Breaking News | Promotions & Moves
Almac Sciences Appoints VP
Dan Bayston has been with the company since 2003.Contract Pharma Staff 10.08.20
-
Breaking News | Industry News
DWK Life Sciences Partners with VMIC
Enters a supply chain agreement to support UK vaccine development.Contract Pharma Staff 10.08.20
-
Breaking News | Collaborations & Alliances | CRO News
BARDA Selects Pharm-Olam for Clinical Trial Planning & Execution Services
Will support new medical countermeasure research in the fight against emerging infectious disease.Contract Pharma Staff 10.08.20
-
Bio News | Bioanalytical Services | Bioassay Development | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Axxam and Fujifilm Cellular Dynamics Enter Alliance
Partner to deliver integrated hiPSC drug discovery solutions.Contract Pharma Staff 10.08.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Delivery | Industry News
HHS Funds Development of Needle-free Vax Technology
Patch could administer vaccines without traditional needles reducing the need for refrigeration in transport and storage, and possibly self-administration.Contract Pharma Staff 10.07.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Eisai Enters Joint Development Agreement for COVID-19 Therapeutics
Aims to understand the mechanism of COVID-19 aggravation based on SARS-CoV-2 infection and to create drugs that prevent the aggravation of COVID-19.Contract Pharma Staff 10.07.20
-
Biologics, Proteins, Vaccines | Breaking News
FDA Issues Guidance on EUA for COVID-19 Vaccines
Provides further information on the EUA process for investigational vaccines.Contract Pharma Staff 10.07.20
-
Breaking News | R&D
Samsung Biologics Adopts Solentim Solutions in R&D Center
Solentim’s instruments will be used in conjunction with Samsung Biologics’ proprietary cell line platform.Contract Pharma Staff 10.07.20
-
Biologics, Proteins, Vaccines | Breaking News | Industry News | Laboratory Testing
CEPI Establishes Global Lab Network to Assess COVID-19 Vax Candidates
Will use the same testing reagents to assess and compare the immunological responses generated by COVID-19 vaccine candidates.Contract Pharma Staff 10.07.20
-
Breaking News | Promotions & Moves
Abenza Appoints SVP and Site Head
Giovanni Escobar brings over 27 years’ experience in the Pharmaceutical industry.Contract Pharma Staff 10.06.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
iBio Enters into Agreement with Safi Biosolutions
To develop growth factors and cytokines using the FastPharming system.Contract Pharma Staff 10.06.20
-
Reader Showcase
Thermo Fisher Scientific Launches Service for Ultra-Low Temp TSX Freezers
Smart connected services enables active sample and product protection.Contract Pharma Staff 10.05.20
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
FibroGenesis Collaborates with R4D Biotech
Expands the fight against COVID-19 in Brazil.Contract Pharma Staff 10.02.20
-
Drug Development
New York City is Not Dead, Our Life Sciences Sector is Thriving
Amid the COVID-19 pandemic, life sciences is booming in NYC!Sara Jane Demy, CEO & Founder, Demy-Colton 10.01.20
-
Breaking News | Drug Development
Olema Completes Series C Financing
Raises $85 million to advance clinical development of OP-1250 in breast cancer.Contract Pharma Staff 10.01.20
-
Breaking News | Promotions & Moves
Boehringer Appoints President of U.S. Fremont Biopharma Biz
Lars Dreesmann will lead the biopharmaceuticals development and manufacturing business.Contract Pharma Staff 10.01.20
-
Capsules | Solid Dosage/Creams/Ointments
Beyond the Boundaries
New capsule types resolve emerging formulation needs.Sven Stegemann, ACG Capsules 09.09.20
-
Clinical Trials | Drug Development
Beyond 2020: The Future of CROs
How will remote site access impact the CRO business?Ryan Jones, CEO, Florence Healthcare 08.21.20
-
Drug Delivery
Not Your Father’s Oral Thin Film
A look at how oral film drug delivery is evolving.Rodolphe Obeid, Vice President of Operations, IntelGenx 06.04.20
-
A Guide to Vaccine Development from Lubrizol Life Science
The current COVID-19 pandemic emphasizes the need for safe and effective vaccines against new pathogens.
-
Clinical Trials | CRO News | Drug Development | Information Technology | R&D
CRO Industry Update
Serge Bodart of IDDI provides insight on the pharma and biopharma trends impacting CROs, outsourcing in today’s market, and advances in clinical research.Kristin Brooks, Contract Pharma 04.27.20
-
Clinical Trials | CRO News | Drug Development | Industry News | Information Technology
Janssen, PRA Design First Mobile Virtual Trial
Kent Thoelke and Greg Licholai of PRA discuss the alliance, advances that have made virtual clinical trials possible, and the obstacles that remainKristin Brooks, Contract Pharma 01.06.20
-
Promotions & Moves
CROS NT Appoints President of North American Ops
Paul has more than 25 years of experience serving customers and managing clinical trials05.30.17
-
APIs | cGMP Manufacture | Industry News
Cambrex Expands Capacity and Capabilites in Sweden
Installs new multi-purpose reactors, adds continuous flow technology at Karlskoga Facility05.30.17
-
cGMP Manufacture | Clinical Trial Materials | Formulation Development | Industry News
Quotient Clinical Appoints Chief Commercial Officer
Kalim to support further expansion of global commercial footprint05.30.17
-
Breaking News | Promotions & Moves
-
Breaking News | Drug Development | Drug Discovery | Facilities | Industry News
-
R&D
Modernizing the R&D Tax Credit
Recognizing a CRO's role in Research and Drug Development
-
Drug Development | Industry News
Q BioMed, ASDERA Enter Licensing Agreement
Q Biomed gains global rights to develop and commercialize ASD-002 to treat rare pediatric disease04.25.17
-
Download the Class II Biological Safety Cabinet Overview
Review the different types of Class II Biosafety Cabinets by downloading this concise 2-page overview
-
Cycle Parameters For Decontaminating A Biological Safety Cabinet Using H2O2 Vapor
Acumen White Papers - Volume 1 No. 2
